Biopharma Quarterly

The Q2 2026 Biopharma Report provides an analysis of recent VC activity and includes a link to our proprietary market map of leading VC-backed companies in the space.

Biopharma VC deal value fell to $7.2 billion in Q1 2026 as capital shifted toward exits. We examine modality trends, oncology, and obesity deal flow, and what a strengthening exit environment means for 2026.

The Q4 2024 Biopharma VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

The Q3 2025 Biopharma VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

The Q2 2025 Biopharma VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

The Q1 2025 Biopharma Modalities VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

The Q4 2024 Biopharma Modalities VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

Vaccine scrutiny could raise clinical trial standards, which poses a risk to fund managers with significant investments in CROs.

The Q3 2024 Biopharma Report provides an overview of industry trends and includes a market map of VC-backed companies. Innovation spotlights include radiopharmaceuticals and AI protein engineering.

The Q2 2024 Biopharma Report provides an overview of industry trends and includes a market map of leading VC-backed companies in the space.

The Q1 2024 Biopharma Report provides an overview of industry trends and includes a market map of leading VC-backed companies in the space.

The Q4 2023 Biopharma Report provides an overview of industry trends and includes a market map of leading VC-backed companies in the space.

The Q3 2023 Biopharma Report provides an overview of industry trends and includes a market map of leading VC-backed companies in the space.